AI Science Tracker

LinearDesign: more stable mRNA sequences designed by an algorithm

Baidu Research · 2 May 2023 · medicine

Discovery

Baidu Research

LinearDesign: more stable mRNA sequences designed by an algorithm

The algorithm, based on a parsing technique from natural-language processing, finds the most stable mRNA sequence for a given protein in about eleven minutes. According to Baidu’s press release, whose study appeared in Nature, sequences produced this way showed greater stability, protein expression and antibody response than comparators in animal experiments. Figures are company-reported; the Baidu release copy on EurekAlert was reviewed, not a baidu.com page.

Technology: LinearDesign

Family LinearDesign: profile · models page

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: direct test
  • Tested: LinearDesign-designed mRNA for COVID-19 and VZV was compared with wildtype and codon-optimized sequences in animal experiments, measuring half-life, expression and antibody response; the figures are company-reported and the release describes no independent replication.
  • Still unknown: The Nature abstract states no specific study limitations and the release states none; the release says benefits such as lower doses and fewer side effects are possibilities not tested.
  • AI role: A parsing-based algorithm (LinearDesign) optimized mRNA structural stability and codon usage for a given protein.

Evidence sources: https://www.eurekalert.org/news-releases/987999 · https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=DOI:10.1038/s41586-023-06127-z&resultType=core&format=json

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: press release. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Citations: in the top 1% of works of the same type, year and subfield (OpenAlex work metrics, 560 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.

Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 4/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open in the full catalog for filters, charts and related discoveries.